Dongwha Pharm Rises 7.5% Amid Pharmaceutical Sector Uptrend

On the 5th, the pharmaceutical sector theme showed a strong performance, rising 3.09% compared to the previous day, with Dongwha Pharm, a related stock, soaring 7.5%. Dongwha Pharm is known as a manufacturer and seller of pharmaceuticals such as Gas Hwal Myung Su and Fusidin.

[Graph] Major stock price changes in the pharmaceutical sector theme



According to provisional data compiled at 10:18, foreigners sold -14,000 shares of Dongwha Pharm, indicating a large net selling by foreign investors.

[Table] Net trading volume of foreigners and institutions (unit: 10,000 shares)



According to the analysis by Thinkpool Robo Algorithm RASSI, Dongwha Pharm’s quant financial score is 36.82 points, with higher stability and profitability scores than the average of other pharmaceutical stocks, ranking 37th within the theme. This indicates that Dongwha Pharm’s ability to respond to internal and external economic environment changes and its efficient profit-generating capability are better compared to other stocks in the theme from a financial perspective.

[Table] Top financial scores within the theme


※ The quant financial score is the result of the Robo Algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.